UBS Group’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
21,038
+20,786
| +8,248% | +$208K | ﹤0.01% | 5450 |
|
|
2025
Q1 | $22.2K | Sell |
252
-21
| -8% | -$1.85K | ﹤0.01% | 6856 |
|
|
2024
Q4 | $25.3K | Buy |
273
+92
| +51% | +$8.53K | ﹤0.01% | 6508 |
|
|
2024
Q3 | $13.3K | Sell |
181
-135
| -43% | -$9.89K | ﹤0.01% | 6387 |
|
|
2024
Q2 | $18.3K | Sell |
316
-5
| -2% | -$290 | ﹤0.01% | 6201 |
|
|
2024
Q1 | $332K | Sell |
321
-29
| -8% | -$30K | ﹤0.01% | 4377 |
|
|
2023
Q4 | $277K | Buy |
350
+30
| +9% | +$23.7K | ﹤0.01% | 4392 |
|
|
2023
Q3 | $152K | Buy |
320
+234
| +272% | +$111K | ﹤0.01% | 4447 |
|
|
2023
Q2 | $51.4K | Sell |
86
-85
| -50% | -$50.8K | ﹤0.01% | 5400 |
|
|
2023
Q1 | $121K | Buy |
+171
| New | +$121K | ﹤0.01% | 4713 |
|
|
2022
Q4 | – | Sell |
-46
| Closed | -$26K | – | 9499 |
|
|
2022
Q3 | $26K | Buy |
+46
| New | +$26K | ﹤0.01% | 5949 |
|
|
2022
Q1 | – | Sell |
-14
| Closed | -$6K | – | 9144 |
|
|
2021
Q4 | $6K | Sell |
14
-17
| -55% | -$7.29K | ﹤0.01% | 8125 |
|
|
2021
Q3 | $23K | Sell |
31
-28
| -47% | -$20.8K | ﹤0.01% | 5872 |
|
|
2021
Q2 | $47K | Buy |
+59
| New | +$47K | ﹤0.01% | 5423 |
|